Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-18T08:52:22.039Z Has data issue: false hasContentIssue false

Assessing the rationale of prescribing carbapenems among hospitalized patients with documented penicillin allergy: implications for stewardship

Published online by Cambridge University Press:  18 March 2024

Anne-Valérie Burgener-Gasser
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Jeanne Fasel
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Delia Halbeisen
Affiliation:
Division of clinical Pharmacy, University Hospital Basel, Basel, Switzerland
Karin Hartmann
Affiliation:
Division of Allergy, Department of Dermatology, University Hospital Basel, Basel, Switzerland
Maja Weisser-Rohacek
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Carole Kaufmann
Affiliation:
Division of clinical Pharmacy, University Hospital Basel, Basel, Switzerland
Sarah Tschudin-Sutter*
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
*
Corresponding author: Sarah Tschudin-Sutter; Email: sarah.tschudin@usb.ch

Abstract

Background:

A reported history of penicillin allergy frequently leads to the prescription of carbapenems as a substitute for penicillin to avoid allergic reactions. Such self-reported allergies need to be accurately characterized to identify targeted antibiotic stewardship interventions that potentially minimize unnecessary carbapenem use.

Design:

Retrospective cohort study.

Method:

The proportion of hospitalized patients with penicillin allergy history receiving carbapenem prescriptions was evaluated between January 1st, 2017 and December 31st, 2018 at the University Hospital Basel, Switzerland. The appropriateness of carbapenem prescription of each patient was evaluated using institutional guidelines based on previously published recommendations.

Results:

Our analysis revealed that among 212 patients with recorded penicillin allergy, of the 247 carbapenem treatment episodes, 79 (32%) were unjustified. Abdominal and lower respiratory tract infections were most frequently associated with inappropriate carbapenem use (OR 2.64, 95% CI 1.22–5.71, P = .014 and OR 2.26, 95% CI 1.08–4.73, P = .031). The recorded allergy type was not documented or unclear in 153 patients (72%) and penicillin allergy was only confirmed in 2 patients (0.9%). Inconsistencies in allergic symptom documentation and allergy types were found between the institution’s two software programs.

Conclusion:

While a multimodal approach to identify and accurately label penicillin allergies remains essential to reduce inappropriate carbapenem use, our findings highlight the need for comprehensive and easily accessible guidelines for carbapenem utilization and structured history-based allergy assessment as an initial screening tool, embedded in a tailored digital allergy record template.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Symptoms of penicillin allergy as recorded in the two software programs (system A and system B)

Figure 1

Table 2.Characteristics of allergic reaction during hospital stay

Figure 2

Table 3.Comparisons between episodes (n=247) with and without unjustified carbapenem use

Figure 3

Table 4.Criteria for carbapenem use14

Supplementary material: File

Burgener-Gasser et al. supplementary material

Burgener-Gasser et al. supplementary material
Download Burgener-Gasser et al. supplementary material(File)
File 107.7 KB